The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127362722 12736272 2 F 20111220 20160901 20160913 20160914 EXP ES-BAXTER-2016BAX045977 BAXTER 61.32 YR Y 0.00000 20160914 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127362722 12736272 1 PS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1050 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 2 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1050 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 3 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1050 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 4 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1050 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 5 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1500 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 6 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown 12142 1500 MG POWDER FOR SOLUTION FOR INJECTION
127362722 12736272 7 SS Rituximab RITUXIMAB 1 Unknown 0 1000 MG
127362722 12736272 8 SS Rituximab RITUXIMAB 1 Unknown 0 1000 MG
127362722 12736272 9 SS Rituximab RITUXIMAB 1 Unknown 0 1000 MG
127362722 12736272 10 SS Rituximab RITUXIMAB 1 Unknown 0 1000 MG
127362722 12736272 11 SS Rituximab RITUXIMAB 1 Unknown 0 1000 MG
127362722 12736272 12 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 120 MG
127362722 12736272 13 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 120 MG
127362722 12736272 14 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 120 MG
127362722 12736272 15 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 120 MG
127362722 12736272 16 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 150 MG
127362722 12736272 17 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown 0 150 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127362722 12736272 1 Chronic lymphocytic leukaemia
127362722 12736272 7 Chronic lymphocytic leukaemia
127362722 12736272 12 Chronic lymphocytic leukaemia

Outcome of event

Event ID CASEID OUTC COD
127362722 12736272 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127362722 12736272 Anaemia
127362722 12736272 Bone pain
127362722 12736272 Fatigue
127362722 12736272 Gastritis
127362722 12736272 Pruritus
127362722 12736272 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127362722 12736272 1 20111129 20111201 0
127362722 12736272 2 20111227 20111230 0
127362722 12736272 3 20120124 20120127 0
127362722 12736272 4 20120222 20120224 0
127362722 12736272 5 20120528 20120530 0
127362722 12736272 6 20120626 20120628 0
127362722 12736272 7 20111227 20111230 0
127362722 12736272 8 20120124 20120127 0
127362722 12736272 9 20120222 20120224 0
127362722 12736272 10 20120326 0
127362722 12736272 11 20120528 20120530 0
127362722 12736272 12 20111129 20111201 0
127362722 12736272 13 20111227 20111230 0
127362722 12736272 14 20120124 20120127 0
127362722 12736272 15 20120222 20120224 0
127362722 12736272 16 20120528 20120530 0
127362722 12736272 17 20120626 20120628 0